Oxford Vaccine for COVID19 Positive RESULTS!!
A COVID‑19 vaccine is a biotechnology intended to provide acquired immunity against coronavirus disease 2019 (COVID‑19). In July 2020, 218 vaccine candidates were in development, although no candidate has completed clinical trials to prove its safety and efficacy. In July, 24 vaccine candidates were announced or undergoing clinical trials, with two beginning Phase III and seven in Phase I-II.
Previous attempts to develop a vaccine against the coronavirus diseases SARS and MERS established considerable knowledge about the structure and function of coronaviruses – which accelerated rapid development during early 2020 of varied technology platforms for a COVID‑19 vaccine – but all the previous coronavirus vaccine candidates failed in early-stage clinical trials, with none being advanced to licensing.
– Wikipedia
